MSR scaffold (IMAGE)
Caption
Attivare will use MSR biomaterial scaffolds like this to first develop treatments for patients with solid tumors and heme malignancies who do not respond to immunotherapies yet.
Credit
Wyss Institute at Harvard University
Usage Restrictions
None
License
Original content